Back exosuits offer the potential to reduce occupational back injuries but require in-field acceptance and use to realize this potential. For this study, 146 employees trialed an active back exosuit in the field for 4 h, completing an acceptance usability survey. Comparing the 80% of employees willing to continue wearing this device (N = 117) to those who were not (N = 29) revealed that employees willing to wear this device for a longer-term study generally were more likely to perceive this back exosuit to be effective (helpful) and compatible (minimally disruptive) to their everyday work.
View Article and Find Full Text PDFIn a prospective cohort study, we tested the hypothesis that children with sickle cell anemia (SCA) with normal transcranial Doppler ultrasound (TCD) velocities and without silent cerebral infarcts (SCIs) would have a lower incidence rate of new neurological events (strokes, seizures or transient ischemic attacks) compared to children with normal TCD measurements and SCIs, not receiving regular blood transfusions. Nonrandomized participants from the silent cerebral infarct transfusion (SIT) Trial who had screening magnetic resonance imaging (MRI) of the brain and normal TCD measurements were included. Follow-up ended at the time of first neurological event (stroke, seizure or transient ischemic attack), start of regular blood transfusion, or loss to follow-up, whichever came first.
View Article and Find Full Text PDF